![]() CROWN LABORATORIES' SKINPEN® REDEFINES AESTHETICS LANDSCAPE WITH DIRE…CROWN LABORATORIES' SKINPEN® REDEFINES AESTHETICS LANDSCAPE WITH... |
SenoVax™ First-in-Class Senolytic Product to be Presented at Society …SenoVax™ First-in-Class Senolytic Product to be Presented at Society for... |
![]() Alchemi's ShieldCRS Platform Honored in 2025 Cybersecurity Excellence…Alchemi's ShieldCRS Platform Honored in 2025 Cybersecurity Excellence... |
AMERICAN TIRE DISTRIBUTORS COMPLETES SALE TRANSACTION WITH LENDER GRO…AMERICAN TIRE DISTRIBUTORS COMPLETES SALE TRANSACTION WITH LENDER GROUP PR... |
![]() Cellectar Biosciences to Report Full Year Financial Results and Host …FLORHAM PARK, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Cellectar... |
![]() New Research: Gen Z's total income reaches $1.1 trillionNew Research: Gen Z's total income reaches $1.1 trillion PR Newswire NEW... |
![]() New Study: Eating Mangos Daily Shown to Improve Insulin Sensitivity a…New Study: Eating Mangos Daily Shown to Improve Insulin Sensitivity and... |
City of Port Jervis Joins the Empire State Purchasing Group for Track…City of Port Jervis Joins the Empire State Purchasing Group for Tracking... |
![]() Cellectar Biosciences to Report Full Year Financial Results and Host …FLORHAM PARK, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Cellectar... |
![]() Cellectar Biosciences to Report Full Year Financial Results and Host …FLORHAM PARK, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Cellectar... |
![]() BlueTree Technologies and Priniv Launch the World's First Reduced-Sug…BlueTree Technologies and Priniv Launch the World's First Reduced-Sugar... |
![]() RXR.Lab Announces IEO Launch of Equity-Based RWA Blockchain Lottery P…Singapore, March 05, 2025 (GLOBE NEWSWIRE) -- RXR.Lab announces its... |
ECB PREVIEW: Last "easy" cut for ECB and eyes on decision wordingThe European Central Bank is expected to enact another 25 basis point interest rate cut this week, but with the outlo ... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions